Search
Human Respiratory Syncytial Virus and Human Rhinovirus are the most frequent cause of respiratory tract infections in infants and children and are major triggers of acute viral bronchiolitis, wheezing and asthma exacerbations.
This is a protocol for a Cochrane Review (intervention). The objectives were to assess the efficacy and safety of whole‐cell pertussis (wP) vaccinations in comparison to acellular pertussis (aP) vaccinations in early infancy for the prevention of atopic diseases in children.
These findings suggest that genetic variants at the VDR locus may play a role in acute wheeze/asthma severity in children
We demonstrate that NOTCH3 is a regulator of MUC5AC production
The expression pattern of FcεRI on DC and basophils differentiates asthmatic from non-asthmatic atopic children
These findings suggest the utility of specific FOT outcomes is dependent on the respiratory disease being assessed
We aimed to research relationships between 25(OH)D levels from birth to 10 y/o and susceptibility to allergic sensitization, respiratory issues and asthma.
Eosinophilic asthma exacerbations may be clinically more severe than non-eosinophilic exacerbation
Type 2 inflammation is present in patients during virus-induced asthma exacerbations, to the same degree as non-viral exacerbations
PLA2R1 is increased in the airway epithelium in asthma, and serves as a regulator of airway hyperresponsiveness, airway permeability, antigen sensitization, and airway inflammation